Viatris Looks To Call It A Day In US Januvia, Janumet Patent Saga
ANDA Sponsor And Originator Merck Look To Settle Hatch-Waxman Case
Viatris and Merck have disclosed plans to settle litigation currently pending before the US Court of Appeals for the Federal Circuit over the ANDA sponsor’s generic versions of its sitagliptin-containing medicines, Januvia (sitagliptin) and Janumet (sitagliptin/metformin).
